药房市场规模、份额及成长分析（按药房、产品供应、可用性、药物类型、药物分子类型和地区）－2025-2032 年产业预测

预计 2023 年药房市场规模将达到 1.5 兆美元，并从 2024 年的 1.58 兆美元增长到 2032 年的 2.45 兆美元，预测期内（2025-2032 年）的复合年增长率为 5.6%。

由于慢性病的增加、医疗保健需求的不断增长以及製药技术的进步，药房市场正在迅速发展。关键成长要素包括个人化医疗需求的不断增长、学名药的普及以及网路药局的扩张。然而，该行业面临严格的监管、开发新药成本高以及定价压力等挑战。儘管存在这些障碍，但受数位健康解决方案、远端医疗服务以及预防性医疗保健需求不断增长等机会的推动，药房市场仍有望增长，尤其是在新兴地区。总体而言，这种动态格局凸显了创新和适应在竞争激烈的製药领域取得成功的必要性。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术分析

药局市场规模：依药局划分

• 市场概览
• 零售药局
• 网路药局
• 医院药房
• 其他药局

药局市场规模（依产品提供）

• 市场概览
• 製药
• 医疗设备
• 其他药品

以库存状况分類的药局市场规模

• 市场概览
• 处方药
• 非处方药

药品市场规模（依药品类型划分）

• 市场概览
• 品牌/专利药品
• 学名药

按药物分子类型分類的药房市场规模

• 市场概览
• 小分子
• 生物製药

按电子药局平台类型分類的药局市场规模

• 市场概览
• 基于应用程式的平台
• 网路为基础的平台

按治疗领域分類的药品市场规模

• 市场概览
• 肿瘤疾病
• 心血管疾病
• 神经系统疾病
• 感染疾病
• 代谢紊乱
• 呼吸系统疾病
• 皮肤病
• 遗传性疾病
• 自体免疫/发炎疾病
• 其他疾病

药局市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• CVS Health Corporation（USA）
• AmerisourceBergen Corporation（USA）
• McKesson Corporation（USA）
• Cardinal Health, Inc.（USA）
• Rite Aid Corporation（USA）
• OptumRx, Inc.（USA）
• Humana Inc.（USA）
• Groupe Pharmagest SA（France）
• MedImpact Healthcare Systems, Inc.（USA）
• AllianceRx Walgreens Prime（USA）
• Benzer Pharmacy（USA）
• Kroger Health（USA）
• HealthWarehouse.com, Inc.（USA）

结论和建议

Pharmacy Market size was valued at USD 1.5 trillion in 2023 and is poised to grow from USD 1.58 trillion in 2024 to USD 2.45 trillion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

The pharmacy market is rapidly evolving, driven by an increase in chronic illnesses, heightened healthcare demands, and advancements in pharmaceutical technology. Key growth factors include the rising need for personalized medicine, the proliferation of generic drugs, and the expansion of online pharmacies. However, the sector faces challenges such as stringent regulations, high R&D costs for new drug development, and pricing pressures. Despite these hurdles, the pharmacy market is poised for growth, fueled by opportunities in digital health solutions, telehealth services, and the rising demand for preventive care, especially in developing regions. Overall, this dynamic landscape underscores the need for innovation and adaptation to thrive in the competitive pharmacy sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pharmacy Market Segments Analysis

Global Pharmacy Market is segmented by Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of E-Pharmacy Platform, Therapeutic Area and region. Based on Pharmacy, the market is segmented into Retail Pharmacy, e-pharmacy, Hospital Pharmacy and Other Pharmacies. Based on Product Offered, the market is segmented into Drugs / Pharmaceuticals, Medical Devices and Other Pharmacy Products. Based on Availability, the market is segmented into Prescription Products and Over-the-counter Products. Based on Type of Drug, the market is segmented into Branded / Patented Drugs and Generic Drugs. Based on Type of Drug Molecule, the market is segmented into Small Molecules and Biologics. Based on Type of e-pharmacy Platform, the market is segmented into App-based Platforms and Web-based Platforms. Based on Therapeutic Area, the market is segmented into Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Metabolic Disorders, Respiratory Disorders, Dermatological Disorders, Genetic Disorders, Autoimmune / Inflammatory Disorders and Other Disorders. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pharmacy Market

Advancements in biotechnology are leading to an increased number of drug developments, particularly in the areas of biosimilars and biologics, which offer enhanced reliability and efficacy for various health conditions. Additionally, the rising significance of customized and personalized genetic information is influencing the demand for tailored medicines and products. These developments are driving significant growth within the pharmacy market, as healthcare providers and patients alike seek innovative solutions that cater to individual health needs, ultimately enhancing treatment outcomes and fostering a more personalized approach to medicine. Overall, these trends are transforming the landscape of the pharmacy sector.

Restraints in the Pharmacy Market

The pharmacy market faces significant constraints due to the high costs associated with developing and bringing new drugs to market, often amounting to millions or even billions of dollars. This financial burden tends to inhibit smaller companies from entering the market and effectively promoting their products. Additionally, a substantial number of drug candidates fail in clinical trials, resulting in considerable financial losses. These challenges collectively hinder the expansion and innovation within the pharmacy industry, as they disproportionately affect smaller players and deter investments needed for research and development. Consequently, the overall growth potential of the pharmacy market is restrained.

Market Trends of the Pharmacy Market

The pharmacy market is witnessing a significant trend towards personalized medicine, fueled by advancements in genomic testing and targeted therapies. This shift is particularly prominent in the management of chronic diseases and oncology, where individualized treatment plans can improve outcomes and enhance patient experiences. The rise of biosimilars and biologics further complements this trend by offering more effective and tailored treatment options for complex health conditions. As healthcare providers and patients increasingly prioritize customized therapies, the pharmacy sector must adapt to meet this growing demand, paving the way for innovative solutions and enhancing overall patient care in an evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global Pharmacy Market Size by Pharmacy & CAGR (2025-2032)

• Market Overview
• Retail Pharmacy
• e-pharmacy
• Hospital Pharmacy
• Other Pharmacies

Global Pharmacy Market Size by Product Offered & CAGR (2025-2032)

• Market Overview
• Drugs / Pharmaceuticals
• Medical Devices
• Other Pharmacy Products

Global Pharmacy Market Size by Availability & CAGR (2025-2032)

• Market Overview
• Prescription Products
• Over-the-counter Products

Global Pharmacy Market Size by Type of Drug & CAGR (2025-2032)

• Market Overview
• Branded / Patented Drugs
• Generic Drugs

Global Pharmacy Market Size by Type of Drug Molecule & CAGR (2025-2032)

• Market Overview
• Small Molecules
• Biologics

Global Pharmacy Market Size by Type of e-pharmacy Platform & CAGR (2025-2032)

• Market Overview
• App-based Platforms
• Web-based Platforms

Global Pharmacy Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Oncological Disorders
• Cardiovascular Disorders
• Neurological Disorders
• Infectious Diseases
• Metabolic Disorders
• Respiratory Disorders
• Dermatological Disorders
• Genetic Disorders
• Autoimmune / Inflammatory Disorders
• Other Disorders

Global Pharmacy Market Size & CAGR (2025-2032)

• North America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • US
  • Canada
• Europe (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Pharmacy, Product Offered, Availability, Type of Drug, Type of Drug Molecule, Type of e-pharmacy Platform, Therapeutic Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CVS Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rite Aid Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptumRx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Groupe Pharmagest S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedImpact Healthcare Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllianceRx Walgreens Prime (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benzer Pharmacy (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kroger Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthWarehouse.com, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations